DGEFX | EPSYX | DGEFX / EPSYX | |
Total Expense Ratio | 0.96 | 0.84 | 114% |
Annual Report Gross Expense Ratio | 1.08 | 0.89 | 121% |
Fund Existence | 8 years | 19 years | - |
Gain YTD | 7.766 | 9.471 | 82% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 468M | 775M | 60% |
Annual Yield % from dividends | 2.49 | 2.27 | 110% |
Returns for 1 year | 16.15 | 8.28 | 195% |
Returns for 3 years | 32.84 | 40.91 | 80% |
Returns for 5 years | 70.99 | 69.60 | 102% |
Returns for 10 years | N/A | 43.63 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNCX | 55.91 | -0.36 | -0.64% |
Janus Henderson Global Life Sciences C | |||
VIGRX | 215.38 | -2.91 | -1.33% |
Vanguard Growth Index Investor | |||
FDCGX | 80.93 | -1.13 | -1.38% |
Fidelity Advisor Consumer Staples C | |||
NSRSX | 47.08 | -0.69 | -1.44% |
Neuberger Berman Small Cap Growth R6 | |||
MSAQX | 22.46 | -0.39 | -1.71% |
Morgan Stanley Inst Asia Opp I |